Question: ArrayIf the applicant adopts a fully outsourced clinical trial approach, how should this clause (30) be understood? (GCP No. 57 of 2020, Article 30) @ @ If it is all outsourced, according to Article 33 of the new version of the Chinese GCP, "the applicant shall still be the ultimate responsible person for the quality and reliability of clinical trial data, and shall supervise the various tasks undertaken by the contract research organization. From the perspective of quality management system, applicants should clarify the responsibilities of all parties, equip qualified personnel, establish appropriate processes, carry out risk based quality management, problem management, etc., to ensure the supervision of clinical trials by applicants.